Company overview
Basic information
Company name
Ortodontijos laboratorija, MB
Company code
306256034
Registered address
Kaunas, Varpo g. 22-19, LT-51363
Registration date
2023-02-24
Company age: 3 y. 8 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Manufacture of medical and dental instruments and supplies
Ownership form
Private without foreign capital
MB "Ortodontijos laboratorija"
Company code: 306256034
Address: Kaunas, Varpo g. 22-19, LT-51363
Description
This description was generated by artificial intelligence.
Ortodontijos laboratorija, MB (company code 306256034) is a private small partnership registered on 24 February 2023 and is currently operational. The company is classified as a micro-sized entity in the national private non-financial companies sector, with private ownership in which Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. Governance is listed as CEO only. The company is based in Kaunas, Kauno m. sav., Kauno apskr., at Varpo g. 22-19, LT-51363. Its main activity is EVRK code C.32.50.90, Manufacture of other medical and dental devices, instruments and supplies. Financially, the company moved from a small loss in its first reported period in 2023 to profitable operations in 2024 and 2025. In 2025, revenue reached €40.8K, up 33.6% year on year from €30.5K in 2024. Net profit was €14.2K in 2025, compared with €16.4K in 2024, and the profit margin was 34.8%. At the end of 2025, equity stood at €13.9K, liabilities at €1.4K, and total assets at €15.3K. The 2023 period closed with a net loss of €325.
Download a detailed company report
Make confident decisions with all the information about Ortodontijos laboratorija, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.